Health
UK begins trial of multivariant Covid-19 vaccine booster – The Tribune India
London, September 21
A phase one trial of a multivariant Covid-19 vaccine booster drug has got underway among participants aged over 60 in the UK.
The trial, involving GRT-R910, has been launched by US pharmaceutical company Gritstone in collaboration with…
Continue Reading
-
General23 hours agoDairy farmers devastated by floods across parts of New South Wales
-
Noosa News20 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
Noosa News22 hours agoMan dies in Gold Coast after rolling trailer pins him to lamp-post
-
General19 hours agoSussan Ley’s office says Bridget McKenzie made false claims about cabinet solidarity